Cardinal Health, Inc. (CAH) may enjoy gains as insiders got busy in the recent days
Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.91 million. Then, WEITZMAN DEBORAH sold […]
Cardinal Health, Inc. [CAH] Shares Jump Approximately 55.73% Over the Year
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately $3.96 million following […]
Recent Insider Activity Suggests Potential Gains for Cardinal Health, Inc. (CAH)
In a filing, Cardinal Health, Inc. revealed its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.89 million. Then, WEITZMAN DEBORAH sold […]
Sharp increase in CAH’s short interest leads to surge in days-to-cover ratio
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately […]
The Potential Rise in the Price of Cardinal Health, Inc. (CAH) following insiders activity
Cardinal Health, Inc.’s filing revealed that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $4.05 million. Then, WEITZMAN DEBORAH sold 6,712 […]
CAH short interest jump by 18.51%, reflecting negative sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately […]
Keeping an Eye on Cardinal Health, Inc. (CAH) After Insider Trading Activity
Cardinal Health, Inc.’s recent filing unveils that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.99 million. Then, WEITZMAN DEBORAH sold 6,712 […]
Cardinal Health, Inc. [CAH] stock for 3,895,411 USD was sold by WEITZMAN DEBORAH
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately $3.93 million following the […]
Argus upgrades Cardinal Health, Inc. (CAH) rating to a Buy
Cardinal Health, Inc.’s recent filing unveils that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.8 million. Then, WEITZMAN DEBORAH sold 6,712 […]
Cardinal Health, Inc. (CAH) Becoming More Attractive for Investors
Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.71 million. Then, WEITZMAN DEBORAH sold 6,712 […]